Cutera, Inc. (NasdaqGS:CUTR) is seeking acquisitions. Chief Financial Officer Rohan Seth said, " Moving on to the balance sheet. Cash and cash equivalents ended the quarter at $164.9 million. This was in large part driven by the issuance of convertible debt in early March, which raised net proceeds of $118 million after $4.2 million of transaction costs and $16.1 million expanded towards the purchase of capped call. Our stated intention is to use the remainder for general corporate purposes, which may include working capital, capital expenditures and potential acquisitions and strategic transactions".
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Companyâs Cutera Core segment consists of the Companyâs systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Companyâs AviClear segment consists of the AviClear business. The Companyâs acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
CUTERA, INC. 
